1 Min Read
Oct 12 (Reuters) - Tg Therapeutics Inc
* Tg therapeutics, inc. To host conference call to provide an update on the genuine phase 3 trial Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.